199 related articles for article (PubMed ID: 14970187)
1. Biologic risk stratification of medulloblastoma: the real time is now.
Fisher PG; Burger PC; Eberhart CG
J Clin Oncol; 2004 Mar; 22(6):971-4. PubMed ID: 14970187
[No Abstract] [Full Text] [Related]
2. Clinical, histopathologic, and molecular markers of prognosis: toward a new disease risk stratification system for medulloblastoma.
Gajjar A; Hernan R; Kocak M; Fuller C; Lee Y; McKinnon PJ; Wallace D; Lau C; Chintagumpala M; Ashley DM; Kellie SJ; Kun L; Gilbertson RJ
J Clin Oncol; 2004 Mar; 22(6):984-93. PubMed ID: 14970185
[TBL] [Abstract][Full Text] [Related]
3. Stratification of medulloblastoma on the basis of histopathological grading.
Giangaspero F; Wellek S; Masuoka J; Gessi M; Kleihues P; Ohgaki H
Acta Neuropathol; 2006 Jul; 112(1):5-12. PubMed ID: 16685513
[TBL] [Abstract][Full Text] [Related]
4. Medulloblastoma: histopathologic and molecular markers of anaplasia and biologic behavior.
Min HS; Lee YJ; Park K; Cho BK; Park SH
Acta Neuropathol; 2006 Jul; 112(1):13-20. PubMed ID: 16691420
[TBL] [Abstract][Full Text] [Related]
5. [Risk stratification in medulloblastoma: screening for molecular markers].
Ebinger M; Senf L; Scheurlen W
Klin Padiatr; 2006; 218(3):139-42. PubMed ID: 16688669
[TBL] [Abstract][Full Text] [Related]
6. Microvessel density and vascular endothelial growth factor expression as predictors of childrens' survival from cerebellar medulloblastoma.
Tural S; Gercek A; Konya D; Ozgen S; Toplamoglu H; Ozek MM
J Clin Neurosci; 2009 Sep; 16(9):1199-202. PubMed ID: 19524442
[TBL] [Abstract][Full Text] [Related]
7. Recurrence in medulloblastoma - influence of clinical, histological and immunohistochemical factors.
Srikantha U; Balasubramaniam A; Santosh V; Somanna S; Bhagavatula ID; Ashwathnarayana CB
Br J Neurosurg; 2010 Jun; 24(3):280-8. PubMed ID: 20465457
[TBL] [Abstract][Full Text] [Related]
8. [Medulloblastoma in children].
Hideghety K; Kerr C; Debrigode C; Dubois JB
Bull Cancer Radiother; 1994; 81(2):143-6. PubMed ID: 7702894
[No Abstract] [Full Text] [Related]
9. Medulloblastoma: tumorigenesis, current clinical paradigm, and efforts to improve risk stratification.
Polkinghorn WR; Tarbell NJ
Nat Clin Pract Oncol; 2007 May; 4(5):295-304. PubMed ID: 17464337
[TBL] [Abstract][Full Text] [Related]
10. Prognostic relevance of clinical and biological risk factors in childhood medulloblastoma: results of patients treated in the prospective multicenter trial HIT'91.
Rutkowski S; von Bueren A; von Hoff K; Hartmann W; Shalaby T; Deinlein F; Warmuth-Metz M; Soerensen N; Emser A; Bode U; Mittler U; Urban C; Benesch M; Kortmann RD; Schlegel PG; Kuehl J; Pietsch T; Grotzer M
Clin Cancer Res; 2007 May; 13(9):2651-7. PubMed ID: 17473196
[TBL] [Abstract][Full Text] [Related]
11. Morphologic peculiarities of anaplastic cerebellar tumors and their prognostic significance.
Kunicki A; Stefanko S; Kukulska Z
Acta Med Pol; 1971; 12(3):319-37. PubMed ID: 5112450
[No Abstract] [Full Text] [Related]
12. Which clinical and biological tumor markers proved predictive in the prospective multicenter trial HIT'91--implications for investigating childhood medulloblastoma.
Grotzer MA; von Hoff K; von Bueren AO; Shalaby T; Hartmann W; Warmuth-Metz M; Emser A; Kortmann RD; Kuehl J; Pietsch T; Rutkowski S
Klin Padiatr; 2007; 219(6):312-7. PubMed ID: 18050040
[TBL] [Abstract][Full Text] [Related]
13. Bcl-2 expression inversely correlates with tumour cell differentiation in medulloblastoma.
Schüller U; Schober F; Kretzschmar HA; Herms J
Neuropathol Appl Neurobiol; 2004 Oct; 30(5):513-21. PubMed ID: 15488027
[TBL] [Abstract][Full Text] [Related]
14. Childhood medulloblastoma.
Walker RW; Rosenblum MK
Rev Neurol (Paris); 1992; 148(6-7):467-76. PubMed ID: 1448667
[TBL] [Abstract][Full Text] [Related]
15. [Medulloblastoma of the cerebellum. Apropos of 120 cases from 1953 to 1982].
Baranzelli MC; Demaille MC; Dhellemmes P; Madelain M; Nuyts JP
Ann Pediatr (Paris); 1986 Feb; 33(2):93-8. PubMed ID: 3963719
[No Abstract] [Full Text] [Related]
16. Histopathological prognostic factors in medulloblastoma: high expression of survivin is related to unfavourable outcome.
Haberler C; Slavc I; Czech T; Gelpi E; Heinzl H; Budka H; Urban C; Scarpatetti M; Ebetsberger-Dachs G; Schindler C; Jones N; Klein-Franke A; Maier H; Jauk B; Kiefer A; Hainfellner JA
Eur J Cancer; 2006 Nov; 42(17):2996-3003. PubMed ID: 16996732
[TBL] [Abstract][Full Text] [Related]
17. Low-level copy gain versus amplification of myc oncogenes in medulloblastoma: utility in predicting prognosis and survival. Laboratory investigation.
Takei H; Nguyen Y; Mehta V; Chintagumpala M; Dauser RC; Adesina AM
J Neurosurg Pediatr; 2009 Jan; 3(1):61-5. PubMed ID: 19119907
[TBL] [Abstract][Full Text] [Related]
18. Gain of 1q is a potential univariate negative prognostic marker for survival in medulloblastoma.
Lo KC; Ma C; Bundy BN; Pomeroy SL; Eberhart CG; Cowell JK
Clin Cancer Res; 2007 Dec; 13(23):7022-8. PubMed ID: 18056178
[TBL] [Abstract][Full Text] [Related]
19. [Histological diagnosis of brain tumors: (19). Medulloblastoma].
Nagashima K
No Shinkei Geka; 1992 Jan; 20(1):9-13. PubMed ID: 1738431
[No Abstract] [Full Text] [Related]
20. Medulloblastoma variants and survival at a children's hospital.
Craver R; Sandquist D; Nadell J; Velez M
Fetal Pediatr Pathol; 2011; 30(1):53-9. PubMed ID: 21204667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]